Skip to content
compulsory patent licensing india

BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

BioSpectrum Asia – Debate over compulsory licensing of Bayer’s Nexavar  Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO… 

biotech plant seed patent india

Economic Times – Monsanto’s Climate Resilient Crop Patent Rejection

Monsanto filed patent application No.2407/DEL/NP/2006 on 01/05/2006. The patent office examined the claimed subject matter and raised objections on various grounds specified under Section 3 of the patents act. Monsanto responded to objections and presented… 

patent filing in india

Global Legal Post – Indian Patent Office Backlog

Global Legal Post Publication Before US visit, PM Modi announced to resolve one the most crucial issues daunting the Indian Patent Office, i.e. clearing the huge backlog. Originally published here. Full Article: 1,000 backlog beaters for… 

pharma patent attorney

Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement

Swissinfo is Swiss Government’s International Publication Service managed by Swiss Broadcasting Corporation (SBC). Originally published here. Views on Delhi High Court’s ruling in Novartis patent dispute: “The ruling is totally in line with existing laws,…